Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes.

Numanagić I, Malikić S, Ford M, Qin X, Toji L, Radovich M, Skaar TC, Pratt VM, Berger B, Scherer S, Sahinalp SC.

Nat Commun. 2018 Feb 26;9(1):828. doi: 10.1038/s41467-018-03273-1.

2.

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.

Pratt VM, Everts RE, Aggarwal P, Beyer BN, Broeckel U, Epstein-Baak R, Hujsak P, Kornreich R, Liao J, Lorier R, Scott SA, Smith CH, Toji LH, Turner A, Kalman LV.

J Mol Diagn. 2016 Jan;18(1):109-23. doi: 10.1016/j.jmoldx.2015.08.005. Epub 2015 Nov 24.

3.

Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.

Kalman LV, Agúndez J, Appell ML, Black JL, Bell GC, Boukouvala S, Bruckner C, Bruford E, Caudle K, Coulthard SA, Daly AK, Del Tredici A, den Dunnen JT, Drozda K, Everts RE, Flockhart D, Freimuth RR, Gaedigk A, Hachad H, Hartshorne T, Ingelman-Sundberg M, Klein TE, Lauschke VM, Maglott DR, McLeod HL, McMillin GA, Meyer UA, Müller DJ, Nickerson DA, Oetting WS, Pacanowski M, Pratt VM, Relling MV, Roberts A, Rubinstein WS, Sangkuhl K, Schwab M, Scott SA, Sim SC, Thirumaran RK, Toji LH, Tyndale RF, van Schaik R, Whirl-Carrillo M, Yeo K, Zanger UM.

Clin Pharmacol Ther. 2016 Feb;99(2):172-85. doi: 10.1002/cpt.280. Epub 2015 Nov 20. Review.

4.

Development of a genomic DNA reference material panel for Rett syndrome (MECP2-related disorders) genetic testing.

Kalman LV, Tarleton JC, Percy AK, Aradhya S, Bale S, Barker SD, Bayrak-Toydemir P, Bridges C, Buller-Burckle AM, Das S, Iyer RK, Vo TD, Zvereff VV, Toji LH.

J Mol Diagn. 2014 Mar;16(2):273-9. doi: 10.1016/j.jmoldx.2013.11.004. Epub 2014 Feb 7.

5.

Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing.

Kalman L, Tarleton J, Hitch M, Hegde M, Hjelm N, Berry-Kravis E, Zhou L, Hilbert JE, Luebbe EA, Moxley RT 3rd, Toji L.

J Mol Diagn. 2013 Jul;15(4):518-25. doi: 10.1016/j.jmoldx.2013.03.008. Epub 2013 May 13.

6.

A dynamic database of microarray-characterized cell lines with various cytogenetic and genomic backgrounds.

Tang Z, Berlin DS, Toji L, Toruner GA, Beiswanger C, Kulkarni S, Martin CL, Emanuel BS, Christman M, Gerry NP.

G3 (Bethesda). 2013 Jul 8;3(7):1143-9. doi: 10.1534/g3.113.006577. Erratum in: G3 (Bethesda). 2013 Sep;3(9):1617.

7.

Quality assurance for Duchenne and Becker muscular dystrophy genetic testing: development of a genomic DNA reference material panel.

Kalman L, Leonard J, Gerry N, Tarleton J, Bridges C, Gastier-Foster JM, Pyatt RE, Stonerock E, Johnson MA, Richards CS, Schrijver I, Ma T, Miller VR, Adadevoh Y, Furlong P, Beiswanger C, Toji L.

J Mol Diagn. 2011 Mar;13(2):167-74. doi: 10.1016/j.jmoldx.2010.11.018.

8.

Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.

Pratt VM, Zehnbauer B, Wilson JA, Baak R, Babic N, Bettinotti M, Buller A, Butz K, Campbell M, Civalier C, El-Badry A, Farkas DH, Lyon E, Mandal S, McKinney J, Muralidharan K, Noll L, Sander T, Shabbeer J, Smith C, Telatar M, Toji L, Vairavan A, Vance C, Weck KE, Wu AH, Yeo KT, Zeller M, Kalman L.

J Mol Diagn. 2010 Nov;12(6):835-46. doi: 10.2353/jmoldx.2010.100090. Epub 2010 Oct 1.

9.

Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent.

Kalman L, Wilson JA, Buller A, Dixon J, Edelmann L, Geller L, Highsmith WE, Holtegaard L, Kornreich R, Rohlfs EM, Payeur TL, Sellers T, Toji L, Muralidharan K.

J Mol Diagn. 2009 Nov;11(6):530-6. doi: 10.2353/jmoldx.2009.090050. Epub 2009 Oct 8.

10.

Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing.

Barker SD, Bale S, Booker J, Buller A, Das S, Friedman K, Godwin AK, Grody WW, Highsmith E, Kant JA, Lyon E, Mao R, Monaghan KG, Payne DA, Pratt VM, Schrijver I, Shrimpton AE, Spector E, Telatar M, Toji L, Weck K, Zehnbauer B, Kalman LV.

J Mol Diagn. 2009 Nov;11(6):553-61. doi: 10.2353/jmoldx.2009.090078. Epub 2009 Sep 18.

11.

Development of genomic reference materials for cystic fibrosis genetic testing.

Pratt VM, Caggana M, Bridges C, Buller AM, DiAntonio L, Highsmith WE, Holtegaard LM, Muralidharan K, Rohlfs EM, Tarleton J, Toji L, Barker SD, Kalman LV.

J Mol Diagn. 2009 May;11(3):186-93. doi: 10.2353/jmoldx.2009.080149. Epub 2009 Apr 9.

12.

p53 prevents the accumulation of double-strand DNA breaks at stalled-replication forks induced by UV in human cells.

Squires S, Coates JA, Goldberg M, Toji LH, Jackson SP, Clarke DJ, Johnson RT.

Cell Cycle. 2004 Dec;3(12):1543-57. Epub 2004 Dec 28.

PMID:
15539956
13.

Regional mapping panels for human chromosomes 1, 2, and 7.

Leonard JC, Toji LH, Bender PK, Beiswanger CM, Beck JC, Johnson RT.

Somat Cell Mol Genet. 1999 Jul;25(4):247-51.

PMID:
11586791
14.

Short tandem repeat profiling provides an international reference standard for human cell lines.

Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, Kelland LR, Harrison M, Virmani A, Ward TH, Ayres KL, Debenham PG.

Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):8012-7. Epub 2001 Jun 19.

15.

Panel description. Regional mapping panels for chromosomes 6, 9, and 16.

Leonard JC, Toji LH, Bender PK, Beiswanger CM, Beck JC, Johnson RT.

Genomics. 1999 Jun 15;58(3):323-6. No abstract available.

PMID:
10373332
16.

Regional mapping panels for chromosomes 8, 13, 21, and 22.

Leonard JC, Toji LH, Bender PK, Beiswanger CM, Beck JC.

Genomics. 1998 Jul 1;51(1):17-20. No abstract available.

PMID:
9693028
17.

Validation of routine mycoplasma testing by PCR.

Toji LH, Lenchitz TC, Kwiatkowski VA, Sarama JA, Mulivor RA.

In Vitro Cell Dev Biol Anim. 1998 May;34(5):356-8. No abstract available.

PMID:
9639095
18.

Regional mapping panels for chromosomes 3, 4, 5, 11, 15, 17, 18, and X.

Leonard JC, Drwinga HL, Kim CH, Toji LH, Bender PK, Mulivor RA, Beck JC.

Genomics. 1997 Dec 15;46(3):530-4.

PMID:
9441767
19.

NIGMS human/rodent somatic cell hybrid mapping panels 1 and 2.

Drwinga HL, Toji LH, Kim CH, Greene AE, Mulivor RA.

Genomics. 1993 May;16(2):311-4.

PMID:
8314568
20.

Characterization of a simian virus 40-transformed Fanconi anemia fibroblast cell line.

Duckworth-Rysiecki G, Toji L, Ng J, Clarke C, Buchwald M.

Mutat Res. 1986 Sep;166(2):207-14.

PMID:
3020399
21.

Cytogenetic manifestations of alteration of gene expression and their relevance to cancer.

Nichols WW, Williams C, Selden JR, Toji L, Girardi A, Bradt C, Hill R.

Prog Clin Biol Res. 1986;209A:591-9. No abstract available.

PMID:
3018771
22.

Characterization of a new human diploid cell line--IMR-91.

Nichols WW, Cristofalo VJ, Toji LH, Greene AE, Aronson MM, Dwight S, Charpentier R, Hoffman E.

In Vitro. 1983 Oct;19(10):797-804.

PMID:
6629383
23.

Induction of sister chromatid exchanges by transformation with simian virus 40.

Nichols WW, Bradt CI, Toji LH, Godley M, Segawa M.

Cancer Res. 1978 Apr;38(4):960-4.

24.

On the "Lucké tumor" origin of cell line LT-1.

Freed JJ, Toji LH, Greene AE.

J Natl Cancer Inst. 1978 Mar;60(3):493-5. No abstract available.

PMID:
304896
25.

Characterization of a new human diploid cell strain, IMR-90.

Nichols WW, Murphy DG, Cristofalo VJ, Toji LH, Greene AE, Dwight SA.

Science. 1977 Apr 1;196(4285):60-3.

PMID:
841339
26.

Techniques in somatic cell genetics as they pertain to senescence of diploid cells.

Nichols WW, Toji LH, Miller RC.

Science. 1973 Dec 14;182(4117):1164-5. No abstract available.

PMID:
17810820
27.

Amniocentesis cells: culture, cryogenic storage, isozymes, and finite life in vitro.

Greene AE, Toji L, Nichols WW, Coriell LL.

In Vitro. 1973 Nov-Dec;9(3):156-9. No abstract available.

PMID:
4779002
28.
29.

Supplemental Content

Support Center